CHTP Financial Facts

Net loss per basic and diluted share of common stock: -0.07
Research and development: 3.95M
See Full Income Statement

Property and equipment, net: -232.9K
Total stockholders' equity: -18.33M
See Full Balance Sheet

Chelsea Therapeutics International (CHTP) Earnings

  |   Expand Research on CHTP
Next EPS Date 5/2/14 *Est. EPS Growth Rate -133.3% *Last Qtr.
Average EPS % Beat Rate +19.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +5.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/11/14 Q413 -$0.07-$0.07 $0.00N/AN/A N/A -10.8% Details
5/1/13 Q113 -$0.06-$0.05 -$0.01N/AN/A N/A +156.6% Details
3/7/13 Q412 -$0.03-$0.08 +$0.05N/AN/A N/A +168% Details
8/7/12 Q212 -$0.12-$0.19 +$0.07N/AN/A N/A 0% Details
3/6/12 Q411 -$0.20-$0.32 +$0.12N/AN/A N/A +38.2% Details
11/2/11 Q311 -$0.18-$0.27 +$0.09N/AN/A N/A +8.5% Details
7/26/11 Q211 -$0.21-$0.25 +$0.04N/AN/A N/A -9.5% Details
5/9/11 Q111 -$0.25-$0.23 -$0.02N/AN/A N/A +9.5% Details